ArticleDiabetology international2016

Efficacy and safety assessment of basal supported oral therapy (BOT) with insulin glargine in a real-life clinical setting, stratified by concomitant orally administered antidiabetic agent (OAD) regimens including dipeptidyl peptidase-4 inhibitor (DPP-4i): subanalysis of the ALOHA2 study, drug-use surveillance in Japan.

Shoko Tsukube et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.